Sinocare Inc.
Status: Publicly traded
Direct answer
Sinocare Inc. is publicly traded on SHZ under the ticker 300298.SZ.
Sinocare Inc., established in 2002 and based in Changsha, People's Republic of China, is dedicated to the research, manufacturing, and marketing of quick diagnostic testing solutions. The company's diverse product range caters to patients with chronic conditions, particularly diabetes, as well as to healthcare professionals. Its offerings include a SARS-CoV-2 antibody test strip, various Safe-Accu and Safe-AQ blood...
Can you invest in Sinocare Inc.?
Yes. Sinocare Inc. trades publicly on SHZ as 300298.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sinocare Inc.
Detailed equity research is provided by MarketSnap.